Masakazu Mimaki

Dr. Masakazu Mimaki

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2025 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
YCYen-Lin Chen
Yen-Lin Chen
BCBrian Hon-Yin Chung
Brian Hon-Yin Chung
MMMasakazu Mimaki
Masakazu Mimaki
SUShumpei Uchino
Shumpei Uchino
YCYin-Hsiu Chien
Yin-Hsiu Chien
NLNi-Chung Lee
Ni-Chung Lee
Complex I of the mitochondrial electron transfer chain is one of the largest membrane protein assemblies ever discovered. A patient carrying a homozygous NDUFB7 intronic mutation died within two months after birth due to cardiorespiratory defects, preventing further study. Here, we report another patient with compound heterozygous mutations in NDUFB7 who suffers from pons abnormality, lactic acidosis, prematurity, prenatal and postnatal growth deficiency, incomplete closure of the abdominal wall (ventral hernia), and a poorly functioning gastrointestinal tract (pseudo-obstruction). We demonstrated that the patient’s skin fibroblasts are deficient in Complex I assembly and reduced supercomplex formation. This report further broadens the spectrum of mitochondrial disorders. The patient has had several surgeries. After receiving treatment with Coenzyme Q10 and vitamin B complex, she has remained stable up to this point. To further explore the functionality of NDUFB7 in vivo, we knocked down Ndufb7 in zebrafish embryos. This resulted in brain ventricle and neuronal defects, elevated lactic acid levels, and reduced oxygen consumption, indicating defective mitochondrial respiration. These phenotypes can be specifically rescued by ectopic expression of ndufb7. More importantly, Mitoquinone mesylate (MitoQ), a common remedy for mitochondrial disorders, can ameliorate these conditions. These results suggest a role for NDUFB7 in mitochondrial activity and the suitability of the zebrafish model for further drug screening and the development of therapeutic strategies for this rare disease.

14 July 2021 in Pain and Therapy
Verified
Journal Article
Open access
PDF file
TNTomohiko Nishino
Tomohiko Nishino
NINaoki Ito
Naoki Ito
STShinya Tomori
Shinya Tomori
SSSatoshi Shimada
Satoshi Shimada
MKMisaki Kodera
Misaki Kodera
MMMasakazu Mimaki
Masakazu Mimaki
Introduction A major goal in neonatal medicine is to reduce stress as much as possible in routine care. Bathing is one of the important routine cares for neonates, but it makes a big environmental change for them. We aimed to examine whether water temperature, room temperature, and position changes in tub bathing serve as noxious stimuli to neonates. Methods This prospective trial was performed in full-term and non-low-birth-weight neonates admitted to the hospital between July 2020 and March 2021. Those with underlying diseases, fetal distress, infection, and other medical conditions were excluded. Measurements were taken during the neonates’ first tub bath since birth, which was performed by a trained nurse. Changes in regional oxygen saturation (rSO2), determined using near-infrared spectroscopy, and water and room temperature, were examined at five different time points: upon entering the bath, head washing, position change, exiting the bath, and during the 3 min after bathing. Results In total, 17 neonates were analyzed. No changes in rSO2 due to head washing or position change were observed; however, rSO2 significantly decreased upon entering (78.5 ± 4.1% vs. 75.7 ± 4.1%, p < 0.001) and exiting the bath (75.8 ± 5.7% vs. 74.4 ± 5.4%, p < 0.04). The rate change in rSO2 upon entering the bath showed a significant inverse correlation with water temperature (r = − 0.53, p < 0.03), and there were no significant correlations between rSO2 and water or room temperature upon exiting the bath. There was no change in body skin temperature before and after bathing, but rSO2 gradually decreased during the 3 min after bathing. Conclusions Neonates may perceive certain temperatures during bathing as noxious stimuli. Therefore, methods to minimize stress associated with bathing should be implemented to reduce the difference between water temperature and room temperature during bathing. Trial registration This trial has been registered at UMIN repository with the trial number UMIN000041045 (https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046500). The date of the final dataset was April 01, 2021.

6 August 2025 in Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
NUNahoko Katayama Ueda
Nahoko Katayama Ueda
MMMasakazu Mimaki
Masakazu Mimaki
SIShota Ito
Shota Ito
AMAyuka Murakami
Ayuka Murakami
SYSatoshi Yokoi
Satoshi Yokoi
YGYu-Ichi Goto
Yu-Ichi Goto
Chronic progressive external ophthalmoplegia (CPEO) is a mitochondrial disease characterized by progressive ptosis and ophthalmoplegia, caused by single deletions, point mutations, or multiple deletions in mitochondrial DNA (mtDNA). Most point mutations occur in tRNA genes. Here, we report a novel variant of the tRNA Glu gene associated with CPEO. A 45-year-old male presented with ptosis and external ophthalmoplegia; however, blood test results, including lactate levels and autoantibodies, were normal. CPEO was suspended, prompting additional myopathological examination, mtDNA sequencing analysis, long polymerase chain reaction (PCR) analysis, and single-fiber analysis to compare mutation loads between ragged-red fibers (RRFs) and non-RRFs. Histopathological examination revealed scattered COX-negative RRFs. No deletions were found in the mtDNA. MtDNA sequencing analysis revealed a novel variant, m.14677 T > C, in the tRNA Glu gene, with Sanger sequencing indicating 45% heteroplasmy in the muscle tissue. Single-fiber analysis showed a significantly higher mutation load of m.14677 T > C in RRFs (range: 25.3–92.8%; median: 88.1%; n = 6) compared with non-RRFs (range: 3.5–85.9%; median: 17.1%; n = 5) (P = 0.03). Based on the significantly higher mutation load in RRFs than in non-RRFs, pathological evidence of mitochondrial disease, and the mutation’s occurrence at an evolutionarily conserved site, we concluded that m.14677 T > C, a novel variant of the tRNA Glu gene, is the cause of CPEO. Biochemical and histopathological examinations of muscle tissue, combined with single-fiber analysis, are valuable tools for evaluating mtDNA variants, particularly those within tRNA genes.

1 January 2022 in Pediatrics International
Verified
Journal Article
Closed access
KYKazuna Yamamoto
Kazuna Yamamoto
KNKozue Nakamura
Kozue Nakamura
RSRyosuke Shiozawa
Ryosuke Shiozawa
SISatoru Iwashima
Satoru Iwashima
MMMasakazu Mimaki
Masakazu Mimaki

1 January 2026 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
STShinya Tomori
Shinya Tomori
KTKazuhiro Takahashi
Kazuhiro Takahashi
TKTakayuki Koyama
Takayuki Koyama
MMMasakazu Mimaki
Masakazu Mimaki

1 January 2026 in Pediatrics International
Verified
Journal Article
Closed access
THToshiyuki Hikita
Toshiyuki Hikita
HHHideki Hoshino
Hideki Hoshino
MMMasakazu Mimaki
Masakazu Mimaki